Trial intelligence / Profile preview

Arginine and N-Acetylcysteine in Hypertensive Diabetic Patients

NCT00569465Phase 4Terminated

Sponsor
University of Turin
Start
Jan 2005
Modality
Peptides, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of arginine, acetylcysteine in type 2 diabetes mellitus (T2DM), hypertension (HTN), sponsored by University of Turin. Started Jan 2005; status: terminated.

02

Drugs

arginineacetylcysteine
03

Conditions

type 2 diabetes mellitus (T2DM)hypertension (HTN)

Beyond the preview

Go deeper on NCT00569465.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00569465.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call